Previous 10 | Next 10 |
Advaxis (NASDAQ: ADXS ) and Personalis (NASDAQ: PSNL ) have collaborated to leverage Personalis’ ImmunoID NeXT Platform in Advaxis’ ongoing Phase 1/2 ADXS-503 (HOT Lung) program evaluating ADXS-503 alone and in combination with pembrolizumab in patients with non-small cell lu...
PRINCETON, N.J. and MENLO PARK, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, and Personalis Inc. (Nasdaq: PSNL), a leader in advanced genomics for ca...
Penny Stocks To Have On The Radar Right Now One of the biggest things to pay attention to when it comes to penny stocks is timing. I’m not saying that you need to perfectly time a trade. This is more in reference to understanding that some times may be better than others to take a clo...
Noteworthy events during the week of February 9 - 15 for healthcare investors. More news on: REGENXBIO Inc., Protalix BioTherapeutics, Inc., AVROBIO, Inc., Healthcare stocks news, , Read more ...
4 Penny Stocks To Watch This Week Let’s call it what it is everyone, coronavirus scared the market into buying anything remotely related to vaccines or respiratory protection. We saw facemask companies skyrocket, cancer stocks turn into coronavirus plays and everything in between. Nee...
Penny Stocks Making Waves This Month Penny stocks offer high risk and high reward option for investors in the stock market. For aggressive investors, it can often prove to be an effective way of making money in the market. At the same time, it should be kept in mind that penny stocks can oft...
PRINCETON, N.J., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced the following upcoming presentations at medical meetings: About Advaxis, Inc...
Advaxis ( ADXS -14.9% ) has signed an agreement with two institutional investors for the purchase and sale of 10M company’s common stock at $1.05 per share, for gross proceeds of $10.5M. More news on: Advaxis, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers : CSS Industries (NYSE: CSS ) +99% . More news on: CSS Industries, Inc., NanoViricides, Inc., Novavax, Inc., Stocks on the move, , Read more ...
The McClatchy (NYSEMKT: MNI ) -14% . More news on: The McClatchy Company, Advaxis, Inc., Tonix Pharmaceuticals Holding Corp., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...
International Zeolite Corp. (IZCFF) is expected to report for Q2 2024 International Stem Cell Corporation (ISCO) is expected to report for Q4 2023 Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4...